FDA Approval The latest news regarding FDA applications, processes, and approval. This section contains releases regarding the Food and Drug Administration’s consideration of new products, drugs, therapies and treatments. Find announcements covering every stage of the FDA application process, from filing to eventual approval, including appeals, resubmissions, and safety alerts.

Feb 19, 2015

08:15 ET

Feb 19, 2015

07:15 ET

Beta O2 Technologies Logo

Feb 17, 2015

05:29 ET

Feb 16, 2015

13:30 ET

Feb 16, 2015

05:17 ET

Feb 16, 2015

04:00 ET

Feb 13, 2015

19:39 ET

Feb 13, 2015

15:55 ET

Feb 13, 2015

11:15 ET

Eisai logo

Feb 13, 2015

10:30 ET

Feb 13, 2015

07:00 ET

Feb 13, 2015

05:53 ET

Feb 13, 2015

00:55 ET

Feb 12, 2015

18:55 ET

Feb 12, 2015

13:29 ET

Feb 12, 2015

13:26 ET

Feb 12, 2015

09:00 ET

The new 0.025 mg/day dosage strength for Minivelle(R) (estradiol transdermal system) is now available in the US for the prevention of postmenopausal osteoporosis.

Feb 11, 2015

13:11 ET

Feb 11, 2015

07:00 ET

Feb 11, 2015

06:30 ET

Jump to news releases